The U.S. Centers for Medicare and Medicaid Services (CMS) approved CT lung cancer screening, stating evidence is sufficient to justify screening for high-risk individuals. This decision - long awaited after the USPSTF grade B recommendation last year and the MEDCAC panel hearing in April - will finally clear the path to implement CT based lung cancer screening in the U.S. for the general public. Read more...